Publications:167
About Me
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Medicine, Liver Diseases
Research Topics
Cancer, Liver
Multi-Disciplinary Training Areas
Cancer Biology [CAB]
Clinical Focus
- Abnormal Liver Enzymes
- Alcoholic Liver Disease
- Autoimmune Liver Disease
- Bile Duct Diseases
- Cholecystitis
- Chronic Liver Disease
- Cirrhosis
- Fatty Liver Disease
- Gallbladder Polyp
- Gallstones
- Gilbert's Syndrome
- HIV-related liver disease
- Hemangioma
- Hemochromatosis
- Hepatic Adenoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatocellular Carcinoma
- Jaundice
- Liver Abscess
- Liver Cancer
- Liver Mass
- Metabolic Dysfunction Associated Steatohepatitis (MASH)
- Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
- Nonalcoholic Fatty Liver Disease
- Nonalcoholic steatohepatitis
- Steatotic Liver Disease
- Toxic Hepatitis
- Wilson's Disease
Video
Education
MD, University of Santiago de Compostela
Residence, Gastroenterology & Hepatology, University Hospital of Santiago de Compostela
PhD, Biomedical Research, University of Santiago de Compostela
MS, Research in Liver Diseases, University of Barcelona
Awards
2018
Junior Faculty Award
GE Liver Gene Expression
2015
Alan Hofmann Clinical and Translational Award in Liver Diseases
American Association for the Study of Liver Diseases Foundation
2013
Rising Star Gastroenterologist, United European Gastroenterology
2008
Sheila Sherlock Fellowship, European Association for the Study of the Liver
2007
Juan Rodes Award, Asociacion Española para el Estudio del Higado
2005
Pedro Barrie de la Maza Fellow, Foundation Banco Pastor
2000
National Award for Excellence in Academic Performance, Ministry of Edication (Goverment of Spain)
Publications
Selected Publications
- The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma. Sudha Kodali, Laura Kulik, Antonio D'Allessio, Eleonora De Martin, Abdul Rahman Hakeem, Monica Lewinska, Stacie Lindsey, Ken Liu, Zorana Maravic, Madhukar S. Patel, David Pinato, Ashwin Rammohan, Nicole Rich, Marco Sanduzzi Zamparelli, David W. Victor, Carmen Vinaxia, Elizabeth W. Brombosz, Augusto Villanueva, Tim Meyer, Nazia Selzner, Rafik Mark Ghobrial, Mohamed Rela, Gonzalo Sapisochin, Maen Abdelrahim, Vatche Agopian, Deniz Balci, Jordi Bruix, Tanios S. Bekaii-Saab, Marina Berenguer, Prashant Bhangui, Sherrie Bhoori, Albert Chi Yan Chan, Stephen L. Chan, Alfred Kow Wei Chieh, Francois Durand, Bijan Eghtesad, Ahmed Elsabbagh, Karim J. Halazun, Milind Javle, Taizo Hibi, Dong Hwan Jung, Korosh Khalili, Jeong Min Lee, Robert Lewandowski, Pal Dag Line, Josep Maria Llovet, Vincenzo Mazzaferro, Valeria Mas, Neil Mehta, Helen Morement, Grainne O'Kane, Valerie Paradis, Neehar Parikh, Anjana Pillai, Wojtek Polak, James Pomposelli, Lorenza Rimassa, Amit Singal, Arvinder Singh Soin, Parissa Tabrizian, Christian Toso, Juan Valle, Eric Vibert, Arndt Vogel, Jessica Zucman Rossi, Kymberly Watt, Andrea Wilson Woods. Liver Transplantation
- Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Sarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris-Oliver, Vincent Vandecaveye, Jordi Abril-Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhoefler, Agavni Mesropian, Júlia Huguet-Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez-Kozlova, Antonio D'Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwalder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet. Journal of Hepatology
- Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis. Kornelius Schulze, Tim Daniel Rose, Lorenz Adlung, Manuela Peschka, Francesca Pagani, Joao Gorgulho, Thorben W. Fründt, Ismail Labgaa, Philipp K. Haber, Carolin Zimpel, Darko Castven, Arndt Weinmann, Teresa Garzia-Lezana, Moritz Waldmann, Thomas Renné, Hannah Voß, Manuela Moritz, Dorian Orlikowski, Hartmut Schlüter, Jan Baumbach, Myron Schwartz, Ansgar W. Lohse, Samuel Huber, Bruno Sangro, Rocio I.R. Macias, Laura Izquierdo-Sanchez, Jesus M. Banales, Henning Wege, Jens U. Marquardt, Augusto Villanueva, Josch Konstantin Pauling, Johann von Felden. JHEP Reports
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Villanueva Rodriguez during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Society of Interventional Oncology
- Genentech, Inc.
- Caris
- Astrazeneca
- Outcomes insights
- Espervita
- Pioneering Medicine
- Medpace, Inc.
- First Word
- Elevar Therapeutics
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Espervita
- Atzeyo Biosensors
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.